Biotricity Inc. (BTCY)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.06
- As of
Kresmion compiles this page from BTCY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BIOTRICITY INC. (BTCY): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-28.
See the full BTCY dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BTCY on one page. Preview it with sample data, then open it live with a free account.
Preview the BTCY dossierActive events for BTCY
- mediumEarnings above estimates
Q1-2026: Beat consensus by 67.3% - EPS $-0.03 vs $-0.0918 estimate
- mediumEarnings above estimates
Q4-2026: Beat consensus by 75.5% - EPS $-0.02 vs $-0.0816 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 63.2% - EPS $-0.03 vs $-0.0816 estimate
- mediumEarnings above estimates
Q2-2026: Beat consensus by 63.2% - EPS $-0.03 vs $-0.0816 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 48.5% - EPS $-0.042 vs $-0.0816 estimate
FREE, NO ACCOUNT
Every event on BTCY, as it fires
You are seeing 5 of 7 events recorded on BTCY since 2026-05-30.
The five above landed across 2 days. The other 2 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, BTCY
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
BTCY against its peers
BTCY's operating margin of 10.6% ranks in the 97th percentile of 17 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-07-31.
| Metric | BTCY | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 16.0M USD | 2.0M USD | 92 | 17 |
| Revenue YoY | 16.0% | n/a | n/a | 4 |
| Gross margin | 80.9% | 52.1% | 83 | 14 |
| Operating margin | 10.6% | -378.2% | 97 | 17 |
| Net margin | -15.0% | -433.0% | 81 | 17 |
| Return on equity | n/a | -219.4% | n/a | 13 |
Peers (21): VTAK, ESMC, POAS, ODYY, NXL, LUDG, NUMD, XAIR, VYCO, NUWE, ADMT, BJDX, IVF, PFSA, RMSL, ADGM, AIDX, FEED, CODX, ALUR, VVOS. Left out: CSDX (no annual filing), FZMD (period gap), EMED (period gap), PMEDF (period gap). Fiscal periods ending between 2025-12-31 and 2026-07-31. Every figure is one full fiscal year read from one annual filing (BTCY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow BTCY on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to BTCY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.